Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet

v3.21.1
Condensed Balance Sheet - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash $ 1,676,347 $ 0
Prepaid expenses 1,416,960 13,162
Total current assets 3,093,307 13,162
Investments held in Trust Account 495,914,245  
Deferred offering costs associated with initial public offering   111,335
Total Assets 499,007,552 124,497
Current liabilities:    
Accounts payable 117,985 52,989
Accrued expenses 73,698 58,385
Note payable - related party   4,053
Total current liabilities 191,683 115,427
Deferred underwriting commissions 17,356,818  
Derivative warrant liabilities 18,047,120  
Total liabilities 35,595,621 115,427
Commitments and Contingencies
Class A ordinary shares; 45,841,193 and -0- shares subject to possible redemption at $10.00 per share at March 31, 2021 and December 31, 2020, respectively 458,411,930  
Shareholders' Equity:    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding at March 31, 2021 and December 31, 2020  
Additional paid-in capital 2,711,759 23,749
Retained earnings (Accumulated deficit) 2,286,616 (15,930)
Total shareholders' equity 5,000,001 9,070
Total Liabilities and Shareholders' Equity 499,007,552 124,497
Common Class A [Member]    
Shareholders' Equity:    
Common stock 375  
Total shareholders' equity 375  
Common Class B [Member]    
Shareholders' Equity:    
Common stock [1] 1,251 1,251
Total shareholders' equity $ 1,251 $ 1,251
[1] This number included up to 1,631,250 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On March 9, 2021, the underwriters partially exercised the over-allotment option to purchase an additional 6,090,908 Units; leaving only 108,523 Class B ordinary shares remain subject to forfeiture. On April 22, 2021, the underwriters’ over-allotment option expired, and the Sponsor forfeited 108,523 shares of Class B ordinary shares accordingly.